Efficacy of Fascia Exercises in Migraine Patients
Launched by ANKARA YILDIRIM BEYAZIT UNIVERSITY · Jan 26, 2024
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
Migraine, which is characterized by attacks and many accompanying symptoms, negatively affects the quality of life of patients. Although different methods have been tried for migraine, there is no definitive treatment approach yet. The aim of this study is to examine the effect of fascia exercises as a new approach on the symptoms and complaints of migraine patients.
The study was completed with 30 volunteer migraine patients. Participants were divided into two groups in a randomized controlled manner. While head-neck and breathing exercises were applied to the control group, fascial patte...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • having a diagnosis of migraine for at least one year
- • between the ages of 18-65 years,
- • having migraine attacks at least 5 days a month,
- • having a history of migraine starting under the age of 50,
- • giving informed written consent to participate in the study
- Exclusion Criteria:
- • headache due to organic or secondary causes (history of subarachnoid or cerebral hemorrhage, hypertension, cerebral embolism or thrombosis),
- • receiving acupuncture treatment in the last 6 months,
- • history of bleeding diathesis or receiving anticoagulant treatment,
- • being pregnant or lactating,
- • history of malignancy,
- • having a diagnosis of depression or receiving antidepressant treatment,
- • caffeine consumption in the last 4 hours,
- • tobacco use in the last 48 hours,
- • drug and alcohol use in the last week,
- • eating within 2 hours prior to the test,
- • being unable to move independently,
- • having an uncontrolled medical condition,
- • chronic cardiovascular disease,
- • recent surgery,
- • symptoms of somatic dysfunction,
- • musculoskeletal injuries,
- • any medication that interferes with the autonomic nervous system or immune system (e.g., beta blockers, steroids, or TNF-a inhibitors)
- • any medical condition that affects the autonomic nervous system or immune system
About Ankara Yildirim Beyazıt University
Ankara Yıldırım Beyazıt University is a leading academic institution in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its expertise in healthcare and innovative research methodologies to conduct ethical and scientifically rigorous clinical studies. By fostering collaboration among multidisciplinary teams, Ankara Yıldırım Beyazıt University aims to contribute to the development of novel therapies and enhance patient care, while adhering to the highest standards of regulatory compliance and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, çubuk, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported